SinoMab BioScience Limited disclosed an updated roster of its Board of Directors, highlighting current roles and committee memberships as of 31 March 2026.

The Board now comprises one executive director, three non-executive directors and five independent non-executive directors. Dr. Shui On Leung continues as both Chairman and Chief Executive Officer, serving concurrently on all three Board committees and leading the Nomination Committee.

Independent non-executive director Mr. Ping Cho Terence Hon chairs the Audit Committee and holds memberships in the Remuneration and Nomination Committees. Dr. Chi Ming Lee heads the Remuneration Committee and sits on the Audit Committee.

Additional independent non-executive directors include Mr. George William Hunter Cautherley, Ms. Chi Sau Giselle Lee and Mr. Nan Shen, each occupying committee positions as outlined in the announcement. Non-executive directors Mr. Xun Dong, Ms. Xiaosu Wang and Dr. Jianmin Zhang remain on the Board without committee assignments.

The company states that Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited assume no responsibility for the contents of the announcement.